The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Intra-arterial Chemotherapy for the Management of Retinoblastoma: Four-Year Experience
Abstract
OBJECTIVE: To determine whether intra-arterial chemotherapy is safe and effective in advanced intraocular retinoblastoma. Retinoblastoma often presents with advanced intraocular disease and, despite conventional treatment with intravenous chemotherapy and external beam radiation therapy, may still require enucleation. DESIGN: Single-arm, prospective registry from May 30, 2006, to May 30, 2010, at an ophthalmic oncology referral center with ambulatory care. A total of 95 eyes of 78 patients with unilateral or bilateral retinoblastoma were treated. The intervention was selective catheterization of the ophthalmic artery and injection of chemotherapy, usually melphalan with or without topotecan. Drug dosage was determined by age and angioanatomy. The main outcome measures were procedural success, event-free (enucleation or radiotherapy) ocular survival, and ocular and extraocular complications. RESULTS: Catheterization succeeded in 98.5% of procedures. There were 289 chemotherapy injections (median, 3 per eye). The Kaplan-Meier estimates of ocular event-free survival rates at 2 years were 70.0% (95% confidence interval, 57.9%-82.2%) for all eyes, 81.7% (95% confidence interval, 66.8%-96.6%) for eyes that received intra-arterial chemotherapy as primary treatment, and 58.4% (95% confidence interval, 39.5%-77.2%) for eyes that had previous treatment failure with intravenous chemotherapy and/or external beam radiation therapy. There were no permanent extraocular complications. CONCLUSION: Our experience suggests that intra-arterial chemotherapy is safe and effective in the treatment of advanced intraocular retinoblastoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.278.15.1262 · Cited by 570
Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma
Eng, C., Li, F. P., Abramson, D. H., Ellsworth, R. M., Wong, F. L., Goldman, M. B., Seddon, J., Tarbell, N., & Boice, J. D. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.14.1121 · Cited by 568
Chemotherapy Plus Local Treatment in the Management of Intraocular Retinoblastoma
Murphree, A. L. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140548005 · Cited by 468
The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma
Yamane, T., Kaneko, A., & Mohri, M. (2004) · International Journal of Clinical Oncology · doi:10.1007/s10147-004-0392-6 · Cited by 316
Chemoreduction and Local Ophthalmic Therapy for Intraocular Retinoblastoma
Friedman, D. L., Himelstein, B., Shields, C. L., Shields, J. A., Needle, M., Miller, D., Bunin, G. R., & Meadows, A. T. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.12 · Cited by 267
ABRAMSON, D. H., & SCHEFLER, A. C. (2004) · Retina · doi:10.1097/00006982-200412000-00002 · Cited by 247
Secondary Acute Myelogenous Leukemia in Patients with Retinoblastoma
Gombos, D. S., Hungerford, J., Abramson, D. H., Kingston, J., Chantada, G., Dunkel, I. J., Antoneli, C. B. G., Greenwald, M., Haik, B. G., Leal, C. A., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.074 · Cited by 210
Superselective Ophthalmic Artery Chemotherapy as Primary Treatment for Retinoblastoma (Chemosurgery)
Abramson, D. H., Dunkel, I. J., Brodie, S. E., Marr, B., & Gobin, Y. P. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.12.030 · Cited by 200
Self-citationThird (fourth and fifth) nonocular tumors in survivors of retinoblastoma
Abramson, D. H., Melson, M. R., Dunkel, I. J., & Frank, C. M. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00713-8 · Cited by 129
Topotecan Combination Chemotherapy in Two New Rodent Models of Retinoblastoma
Laurie, N. A., Gray, J., Zhang, J., Leggas, M. L., Relling, M. V., Egorin, M. J., Stewart, C. F., & Dyer, M. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0849 · Cited by 127
Cited by
Dimaras, H., Corson, T. W., Cobrinik, D., White, A., Zhao, J., Munier, F. L., Abramson, D. H., Shields, C. L., Chantada, G. L., Njuguna, F., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.21 · Cited by 553
Intra-arterial Chemotherapy for Retinoblastoma: A Systematic Review
Yousef, Y. A., Soliman, S. E., Astudillo, P. P. P., Durairaj, P., Dimaras, H., Chan, H. S. L., Héon, E., Gallie, B. L., & Shaikh, F. (2016) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2016.0244 · Cited by 370
Understanding pRb: toward the necessary development of targeted treatments for retinoblastoma
Sachdeva, U. M., & O’Brien, J. M. (2012) · Journal of Clinical Investigation · doi:10.1172/jci57114 · Cited by 67
Metadata
- Authors
- Gobin, Y. P.
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2011-06-13
- Volume
- 129
- Issue
- 6
- Pages
- 732
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W2142480746
- Cited by
- 439
- References
- 16
- FWCI
- 35.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intra-arterial Chemotherapy for the Management of Retinoblastoma: Four-Year Experience. https://app.cochat.ai/papers/10.1001/archophthalmol.2011.5
- The paper
- Gobin, Y. P. (2011). Intra-arterial Chemotherapy for the Management of Retinoblastoma: Four-Year Experience. Archives of Ophthalmology. https://doi.org/10.1001/archophthalmol.2011.5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.